EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both chemo-free IO-IO and IO-IO-chemo triple combinations
The award recognizes and supports promising female scientists working in mass spectrometry
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
Essex enriches and complements Emmes’ services
Women of all ages will get round-the-clock access to comprehensive treatment
Integration of modern and traditional medicine to facilitate the illness to wellness journey
Subscribe To Our Newsletter & Stay Updated